Sign In
Buy ABSI
$5.94
-0.410 (-6.46%)
At Close: Jun 03, 2026
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 06'th Mar 2026
VANCOUVER, Wash. and NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generat
Absci Corporation (ABSI) Presents at TD Cowen 46th Annual Health Care Conference Transcript
02:46pm, Friday, 06'th Mar 2026
Absci Corporation (ABSI) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Absci Conference: Agentic AI Push and ABS-201 Hair-Loss Program Take Center Stage
01:34am, Wednesday, 04'th Mar 2026
Executives from Absci (NASDAQ: ABSI) used a conference presentation to emphasize the company's focus on building clinical-stage drug assets using artificial intelligence, with management repeatedly fr
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
08:00am, Tuesday, 03'rd Mar 2026
Former Vertex executive to spearhead the clinical development of Absci's expanding AI-designed therapeutics pipeline Chief Innovation Officer Andreas Busch to retire March 31, 2026 and will continue t
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026
08:00am, Tuesday, 24'th Feb 2026
VANCOUVER, Wash. and NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generati
Absci to Participate in Upcoming Investor Conferences
08:00am, Tuesday, 17'th Feb 2026
VANCOUVER, Wash. and NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, to
The Genesis Mission Has a 270-Day Timeline – And You’re Already Late
12:00am, Tuesday, 27'th Jan 2026
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Absci Corporation (ABSI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
10:16pm, Wednesday, 14'th Jan 2026
Absci Corporation (ABSI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Absci Corporation (NASDAQ:ABSI) Given Consensus Rating of “Moderate Buy” by Brokerages
01:23am, Friday, 02'nd Jan 2026
Shares of Absci Corporation (NASDAQ: ABSI - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the company, Market
The Genesis Mission Has a 270-Day Timeline – And You’re Already Late
12:00am, Saturday, 20'th Dec 2025
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade
12:00am, Saturday, 20'th Dec 2025
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference
08:00am, Tuesday, 16'th Dec 2025
VANCOUVER, Wash. and NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, to
Absci Corporation (ABSI) Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia Transcript
04:52pm, Thursday, 11'th Dec 2025
Absci Corporation (ABSI) Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia Transcript
Inhibiting prolactin receptor (PRLR) signaling with the ABS-201 anti-PRLR antibody promotes human hair follicle growth ex vivo
Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research
08:00am, Wednesday, 10'th Dec 2025
Partnership aims to destigmatize androgenetic alopecia and highlight the need for new therapeutic options that address the root cause of disease
